XML 14 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net income $ 3,666,959 $ 3,420,721
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of convertible notes (132,300)
Change in fair value of warrant liabilities (3,792,273) (3,978,333)
Transaction costs allocated from initial public offering 481,824
Interest earned on investment held in Trust Account (7,090)
Prepaid expenses 14,237 (545,650)
Accounts payable and accrued expenses (80,290) 75,000
Net cash used in operating activities (330,757) (546,438)
Cash Flows from Investing Activities:    
Investment of cash into trust Account (250,000,000)
Net cash used in investing activities (250,000,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 245,000,000
Proceeds from sale of Private Placements Warrants 6,750,000
Proceeds from promissory note – related party 141,367
Repayment of promissory note – related party (10,123)
Proceeds from convertible promissory note - related party 500,000
Payment of offering costs (476,846)
Net cash provided by financing activities 500,000 251,429,398
Net Change in Cash 169,243 882,960
Cash – Beginning of period 366,612
Cash – End of period 535,855 882,960
Non-Cash Investing and Financing Activities:    
Offering costs included in accrued offering costs 10,000
Offering costs paid through promissory note 10,123
Accretion for Class A common stock to redemption amount 22,098,478
Deferred underwriting fee payable $ 8,750,000